ANGLE plc (LON:AGL – Get Free Report)’s share price was up 11.9% during trading on Thursday . The company traded as high as GBX 8.95 ($0.12) and last traded at GBX 8.95 ($0.12). Approximately 1,432,675 shares were traded during mid-day trading, a decline of 3% from the average daily volume of 1,476,119 shares. The stock had previously closed at GBX 8 ($0.11).
Wall Street Analysts Forecast Growth
Separately, Berenberg Bank reaffirmed a “buy” rating and set a GBX 40 ($0.53) price target on shares of ANGLE in a research note on Wednesday, January 29th.
Get Our Latest Research Report on AGL
ANGLE Price Performance
ANGLE Company Profile
ANGLE plc, a medical diagnostic company, engages in developing cancer diagnostics products in Europe, North America, and the United Kingdom. The company develops and commercializes Parsortix cell separation system, which captures and harvests circulating tumor cells in metastatic breast cancer patient blood; and HyCEAD.
Read More
- Five stocks we like better than ANGLE
- How Can Retail Investors Trade the Toronto Stock Exchange (TSX)?
- Goldman Sachs Just Revealed What’s Next for Markets
- Uptrend Stocks Explained: Learn How to Trade Using Uptrends
- Buy the Boeing Dip Even on Tariff and Bans?
- 3 Warren Buffett Stocks to Buy Now
- 3 High Short Interest Stocks Set to Pop After Tariff Fears Fade
Receive News & Ratings for ANGLE Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ANGLE and related companies with MarketBeat.com's FREE daily email newsletter.